SecBot SecBot
COURT-RULING ·Filed Apr 24, 2026

CI

Cigna Group
NEUTRAL
Impact 3/10
Horizonweeks Processed6mo ago CourtCourt Ruling · courtlistener.com
Court ruling (appellate)
Actionable Insight • Neutral

The ruling reduces near-term litigation risk but does not resolve underlying claims. Traders should monitor for any renewed motions or settlements in the district court. Given the non-precedential nature of the decision, it has minimal impact on future ERISA litigation risk.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$275.24
T+0 close · Apr 24, 2026 · via day close
Latest settled
+3.16%
T+60 · $283.94
Vs SPY
−0.78%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 24 $275.24entry
  2. T+1 · 7mo ago +2.55%α +2.39% · $282.26
  3. T+5 · 7mo ago +5.57%α +4.67% · $290.58
  4. T+20 · 6mo ago +2.46%α −1.56% · $282.02
  5. T+60 · 4mo ago +3.16%α −0.78% · $283.94
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

The Second Circuit affirmed a lower court's denial of a motion for post-judgment discovery and accounting in the ERISA class action Amara v. Cigna Corp., upholding the district court's interpretation of prior orders. The ruling ends a procedural avenue for plaintiffs but does not alter the underlying liability or damages.

Court Ruling Details

Ruling Date
Apr 24, 2026
Court
Court of Appeals for the Second Circuit
Court Level
Appellate
Judge
Debra A. Livingston
Case Type
employment
Ruling Type
procedural
Outcome
WIN: ruling favors this company
Appeal Timeline
60 days for petition for rehearing en banc
Precedent Risk
LOW

Key Facts

  • Second Circuit affirmed the district court's denial of a motion for accounting and post-judgment discovery in an ERISA case involving Cigna Corp.
  • The plaintiffs, representing a class, argued errors in the district court's interpretation of prior orders but failed to meet the burden of showing 'significant questions regarding noncompliance.'
  • The appellate court applied de novo review to the legal interpretation of prior orders and found no abuse of discretion.
  • This is a summary order, which has no precedential effect under Second Circuit rules.

Financial Impact

No new damages or financial remedies imposed; procedural denial only.

legal_exposurelitigation_risk

Risk Factors

  • Potential for renewed discovery motions or appeals if plaintiffs seek rehearing or Supreme Court review.
  • Ongoing reputational and legal risk from unresolved ERISA compliance questions.

Market Snapshot

Exchange
NYSE
Sector
Hospital & Medical Service Plans

Investment Themes

Traditional Finance

Documents Analyzed

This report is based on 1 court opinion.

DocumentAccession Number
COURT-RULING Data (Synthetic)court-tdivksak-CI

Track record

16 reports on CI

Performance horizon

The track record builds as more bullish or bearish reports settle.

Filters
  1. Nov 5, 202611d ago 8-K Bullish 6/10 Entry $301.48 to $296.27 Now $297.00 −1.49% ▼ −1.73% −5.02% vs SPY
  2. Oct 28, 202619d ago Press Release Neutral 2/10 Entry $298.41 to $301.48 Now $297.00 −0.47% ▲ +1.03% +5.75% vs SPY
  3. Oct 27, 202620d ago Institutional Cluster Mixed 3/10 Entry $295.00 to $305.41 Now $297.00 +0.68% ▲ +3.53% +4.24% vs SPY
  4. Oct 20, 202627d ago Institutional Cluster Neutral 3/10 Entry $304.37 to $298.28 Now $297.00 −2.42% ▼ −2.00% −1.56% vs SPY
  5. Oct 9, 20265w ago 8-K Neutral 2/10 Entry $283.34 to $298.50 Now $297.00 +4.82% ▲ +5.35% +6.84% vs SPY
  6. Sep 30, 20266w ago 8-K Neutral 4/10 Entry $271.83 to $278.51 Now $297.00 +9.26% ▲ +2.46% +0.54% vs SPY
  7. Sep 3, 202610w ago 144 Neutral 2/10 Entry $286.26 to $280.76 Now $297.00 +3.75% ▼ −1.92% −0.77% vs SPY
  8. Aug 18, 202612w ago 144 Neutral 2/10 Entry $278.50 to $279.32 Now $297.00 +6.64% ▲ +0.29% +0.50% vs SPY
  9. Aug 4, 202614w ago 144 Neutral 2/10 Entry $273.45 to $273.87 Now $297.00 +8.61% ▲ +0.16% +0.25% vs SPY
  10. Jul 9, 202618w ago 3 Neutral 2/10 Entry $293.46 to $283.82 Now $297.00 +1.21% ▼ −3.28% −2.72% vs SPY
Showing 10 of 16

US Market Status

Market Closed · Opens Wed (12h 8m)

Subscribe to SecBot

Get Real-Time Court Ruling Intelligence

Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more, parsed and scored by AI.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
⚖ Court Ruling · courtlistener.com Report published Apr 24, 2026